Literature DB >> 17386345

Supplementation with vitamins C and E improves arterial stiffness and endothelial function in essential hypertensive patients.

Yvonne Plantinga1, Lorenzo Ghiadoni, Armando Magagna, Chiara Giannarelli, Ferdinando Franzoni, Stefano Taddei, Antonio Salvetti.   

Abstract

BACKGROUND: Essential hypertension is characterized by endothelial dysfunction, arterial stiffness, and increased oxidative stress. We evaluated the effect of short-term combined treatment with the antioxidants vitamins C and E on endothelial function, arterial stiffness, and oxidative stress in untreated essential hypertensive patients.
METHODS: A randomized, double-blind, placebo-controlled, crossover study design was used to assign 30 male essential hypertensive patients to either vitamin C (1 g) and vitamin E (400 IU) or placebo for 8 weeks. Endothelium-dependent response was assessed as flow-mediated dilation (FMD) of the brachial artery. Arterial stiffness was assessed as central pulse wave velocity (PWV) and augmentation index (AIx). Plasma markers of oxidative stress and antioxidant status were measured.
RESULTS: After vitamin supplementation, FMD was significantly improved. Central PWV was significantly reduced, while AIx tended to decrease. Plasma vitamin levels and antioxidant capacity increased significantly. Levels of oxidative stress decreased. Changes in central PWV were related to changes in levels of oxidative stress.
CONCLUSIONS: Combined treatment with vitamins C and E has beneficial effects on endothelium-dependent vasodilation and arterial stiffness in untreated, essential hypertensive patients. This effect is associated with changes in plasma markers of oxidative stress.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17386345     DOI: 10.1016/j.amjhyper.2006.09.021

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  56 in total

Review 1.  Effects of vitamin C supplementation on blood pressure: a meta-analysis of randomized controlled trials.

Authors:  Stephen P Juraschek; Eliseo Guallar; Lawrence J Appel; Edgar R Miller
Journal:  Am J Clin Nutr       Date:  2012-04-04       Impact factor: 7.045

2.  Effects of pomegranate juice supplementation on pulse wave velocity and blood pressure in healthy young and middle-aged men and women.

Authors:  Anthony Lynn; Hiba Hamadeh; Wing Chi Leung; Jean M Russell; Margo E Barker
Journal:  Plant Foods Hum Nutr       Date:  2012-09       Impact factor: 3.921

3.  Dynamic evaluation of renal resistive index in normoalbuminuric patients with newly diagnosed hypertension or type 2 diabetes.

Authors:  R M Bruno; E Daghini; L Landini; D Versari; A Salvati; E Santini; I Di Paco; A Magagna; S Taddei; L Ghiadoni; A Solini
Journal:  Diabetologia       Date:  2011-04-16       Impact factor: 10.122

4.  The effect of oral antioxidants on brachial artery flow-mediated dilation following 5 and 10 min of ischemia.

Authors:  Ryan A Harris; Steven K Nishiyama; D Walter Wray; Vince Tedjasaputra; Damian M Bailey; Russell S Richardson
Journal:  Eur J Appl Physiol       Date:  2009-08-11       Impact factor: 3.078

5.  Run for your life: exercise, oxidative stress and the ageing endothelium.

Authors:  M A Denvir; G A Gray
Journal:  J Physiol       Date:  2009-09-01       Impact factor: 5.182

Review 6.  Nutraceuticals and Blood Pressure Control: Results from Clinical Trials and Meta-Analyses.

Authors:  Arrigo F G Cicero; Alessandro Colletti
Journal:  High Blood Press Cardiovasc Prev       Date:  2015-03-19

7.  Osteopontin is associated with increased arterial stiffness in rheumatoid arthritis.

Authors:  Laura Bazzichi; Lorenzo Ghiadoni; Alessandra Rossi; Melania Bernardini; Mario Lanza; Francesca De Feo; Camillo Giacomelli; Ilaria Mencaroni; Katia Raimo; Marco Rossi; Anna Maria Mazzone; Stefano Taddei; Stefano Bombardieri
Journal:  Mol Med       Date:  2009-06-18       Impact factor: 6.354

8.  Effect of disodium EDTA chelation regimen on cardiovascular events in patients with previous myocardial infarction: the TACT randomized trial.

Authors:  Gervasio A Lamas; Christine Goertz; Robin Boineau; Daniel B Mark; Theodore Rozema; Richard L Nahin; Lauren Lindblad; Eldrin F Lewis; Jeanne Drisko; Kerry L Lee
Journal:  JAMA       Date:  2013-03-27       Impact factor: 56.272

Review 9.  Alzheimer's disease and endothelial dysfunction.

Authors:  Giuseppe Bomboi; Lorenzo Castello; Francesco Cosentino; Franco Giubilei; Francesco Orzi; Massimo Volpe
Journal:  Neurol Sci       Date:  2009-10-17       Impact factor: 3.307

10.  DASH lowers blood pressure in obese hypertensives beyond potassium, magnesium and fibre.

Authors:  Y Al-Solaiman; A Jesri; W K Mountford; D T Lackland; Y Zhao; B M Egan
Journal:  J Hum Hypertens       Date:  2009-07-23       Impact factor: 3.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.